22 Results for "

RIP2

" in MedChemExpress (MCE) Product Catalog:
Products (22)

22 Results for "RIP2" in MCE Product Catalog:

9
9 Publications Verification
Cat. No.: HY-100339
CAS No.: 1346547-00-9
Purity:  99.93%
Target:  

RIP kinase

Research Areas:  

Endocrinology

GSK583 is a highly potent, orally active and selective inhibitor of RIP2 Kinase, with IC50 of 5 nM. GSK583 inhibits both TNF-α and IL-6 production with an IC50 value of 200 nM.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-112038A
Purity:  98.82%
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

GSK2983559 is an orally active and potent receptor interacting protein 2 (RIP2) kinase inhibitor. GSK2983559 blocks many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-112038
CAS No.: 1579965-12-0
Purity:  99.90%
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

GSK2983559 free acid (compound 3) is an orally active and potent receptor interacting protein 2 (RIP2) kinase inhibitor. GSK2983559 free acid can block many proinflammatory cytokine responses in vivo and in human inflammatory bowel disease explant samples .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-19761
CAS No.: 1581270-11-2
Target:  

RIP kinase

Research Areas:  

Cancer

RIP2 kinase inhibitor 2 is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043437 A1, compound example 9.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19764
CAS No.: 1423186-80-4
Target:  

RIP kinase

Research Areas:  

Cancer

GSK2983559 active metabolite is an active metabolite of GSK2983559. GSK2983559 active metabolite is a receptor interacting protein-2 (RIP2) kinase inhibitor extracted from patent WO/2014043446 A1, compound example 1.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P5524A
Synonyms: Lauroyl-γ-D-glutamyl-meso-diaminopimelic acid hydrochloride; γ-D-glutamyl-meso-diaminopimelic acid hydrochloride
C12-iE-DAP hydrochloride (Lauroyl-γ-D-glutamyl-meso-diaminopimelic acid hydrochloride) is a highly potent and selective NOD1 agonist, with an EC50 of 0.027 nM in HEK-Blue cells expressing human NOD1. C12-iE-DAP hydrochloride activates the NOD1/RIPK2 signaling pathway and its downstream p38 MAPK and NF-κB, induces the expression of inflammatory mediators such as IL6 and IL8, and exerts synergistic effects with TLR4, Dectin-1 or Mincle signaling. C12-iE-DAP hydrochloride can be used in studies related to vascular inflammation, tumor metastasis and neuroinflammation [2] .
loading...
    loading...
Cat. No.: HY-N0600
CAS No.: 62025-50-7
Ginsenoside F3 is a saponin extracted from the leaves of Panax ginseng with immunoenhancing and antitumor immunostimulatory activities. Ginsenoside F3 upregulates RIPOR2 with a Kd value of 3.77 μM. Ginsenoside F3 enhances NF‑κB activation, upregulates T‑bet and downregulates GATA‑3, increases the production of IL‑2 and IFN‑γ, decreases the production of IL‑4 and IL‑10, reverses CD8⁺ T‑cell exhaustion, restores cytokine secretion, and enhances antitumor immunity in a mouse non‑small cell lung cancer model. Ginsenoside F3 can be used for the research of non-small cell lung cancer [2].
loading...
    loading...
Cat. No.: HY-111870
CAS No.: 2089205-64-9
Purity:  99.97%
Target:  

PROTACs RIP kinase

Research Areas:  

Cancer

PROTAC RIPK degrader-6 (example 1) is a Cereblon-based PROTAC targeting RIP Kinase degradation wherein the RIP2 kinase inhibitor is linked via a linker to a cereblon binder .
loading...
    loading...
Cat. No.: HY-136010
CAS No.: 2126803-41-4
Target:  

RIP kinase PROTACs

Research Areas:  

Inflammation/Immunology

RIP2 Kinase Inhibitor 4 is a potent and selective RIPK2 PROTAC. RIP2 Kinase Inhibitor 4 effectively degrades RIPK2 (pIC50 of 8) and inhibits the release of related TNF-α .
loading...
    loading...
Cat. No.: HY-133014
CAS No.: 2380028-10-2
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

RIP2 kinase inhibitor 1 (compound 11) is a potent and selective receptor interacting protein 2 (RIP2) kinase inhibitor with an IC50 of 0.03 μM for RIP2 FP. RIP2 kinase inhibitor 1 is used for autoinflammatory disorders .
loading...
    loading...
Cat. No.: HY-112907
CAS No.: 1398053-50-3
Purity:  99.76%
Target:  

RIP kinase

Research Areas:  

Inflammation/Immunology

RIP2 Kinase Inhibitor 3 is a highly potent and selective inhibitor of receptor interacting protein-2 (RIP2) Kinase with an IC50 of 1 nM .
loading...
    loading...
Cat. No.: HY-147235
CAS No.: 2143956-20-9
Target:  

RIP kinase PROTACs

Research Areas:  

Infection

RIPK2-IN-2 (example 25) is a RIP2 kinase PROTAC inhibitor. RIPK2-IN-2 can block RIP2-dependent proinflammatory signaling, regulated RIP2 kinase activity in auto inflammatory diseases .
loading...
    loading...
Cat. No.: HY-P5524
CAS No.: 1269619-57-9
Synonyms: Lauroyl-γ-D-glutamyl-meso-diaminopimelic acid; γ-D-glutamyl-meso-diaminopimelic acid
C12-iE-DAP (Lauroyl-γ-D-glutamyl-meso-diaminopimelic acid) is a highly potent and selective NOD1 agonist, with an EC50 of 0.027 nM in HEK-Blue cells expressing human NOD1. C12-iE-DAP activates the NOD1/RIPK2 signaling pathway and its downstream p38 MAPK and NF-κB, induces the expression of inflammatory mediators such as IL6 and IL8, and exerts synergistic effects with TLR4, Dectin-1 or Mincle signaling. C12-iE-DAP can be used in studies related to vascular inflammation, tumor metastasis and neuroinflammation [2] .
loading...
    loading...
Cat. No.: HY-118316
CAS No.: 899758-61-3
Research Areas:  

Inflammation/Immunology

GSK223 is a quinazolinone NOD1 pathway inhibitor with potential anti-inflammatory activity. GSK223 can selectively inhibit IL-8 release under iE-DAP stimulation without affecting IL-8 secretion caused by TNF receptor, TLR2 or NOD2 agonists. GSK223 does not directly inhibit RIP2 kinase activity.
loading...
    loading...
Cat. No.: HY-184890
CAS No.: 1346547-39-4
Research Areas:  

Cancer

RIP2K-ligand-1 is a PROTAC target protein ligand targeting RIP2K, which is applicable to research related to PROTAC synthesis. RIP2K-ligand-1 serves as the target protein ligand for PROTAC RIPK degrader-6 (HY-111870) .
loading...
    loading...
Cat. No.: HY-100339R
CAS No.: 1346547-00-9
Research Areas:  

Endocrinology

GSK583 (Standard) is the analytical standard of GSK583 (HY-100339). This product is intended for research and analytical applications. GSK583 is a highly potent, orally active and selective inhibitor of RIP2 Kinase, with IC50 of 5 nM. GSK583 inhibits both TNF-α and IL-6 production with an IC50 value of 200 nM.
loading...
    loading...
Cat. No.: HY-RS12002
Research Areas:  

Others

RIPOR2 Human Pre-designed siRNA Set A contains three designed siRNAs for RIPOR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS00957
Research Areas:  

Others

ARHGEF28 Human Pre-designed siRNA Set A contains three designed siRNAs for ARHGEF28 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS11995
Research Areas:  

Others

RIPK2 Human Pre-designed siRNA Set A contains three designed siRNAs for RIPK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS11996
Research Areas:  

Others

Ripk2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ripk2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...